Efficacy and Predictors of Response to Fampridine in a Sample of Patients with Multiple Sclerosis: a Real-Life Study

被引：0
|
作者：
Martinez, Elisa [1 ,2 ]
Robles Sanchez, Miguel Angel [1 ,2 ]
Horno, Rosalia [1 ,2 ]
Castillo-Justribo, Joaquin [1 ,2 ]
Vidal-Jordana, Angela [1 ,2 ]
Zabalza, Ana [1 ,2 ]
Rodriguez, Breogan [1 ,2 ]
Vilaseca, Andreu [1 ,2 ]
Arrambide, Georgina [1 ,2 ]
Pappolla, Agustin [1 ,2 ]
Midaglia, Luciana [1 ,2 ]
Galan, Ingrid [1 ,2 ]
Arino, Helena [1 ,2 ]
Carvajal, Rene [1 ,2 ]
Mongay-Ochoa, Neus [1 ,2 ]
Cobo Calvo, Alvaro [1 ,2 ]
Comabella, Manuel [1 ,2 ]
Sastre-Garriga, Jaume [1 ,2 ]
Tintore, Mar [1 ,2 ]
Montalban, Xavier [1 ,2 ]
Rio, Jordi [1 ,2 ]
机构：
[1] Vall Hebron Univ Hosp & Res Inst VHIR, Multiple Sclerosis Ctr Catalonia Cemcat, Barcelona, Spain
[2] Vall Hebron Univ Hosp & Res Inst VHIR, Dept Neurol, Barcelona, Spain
来源：
MULTIPLE SCLEROSIS JOURNAL | 2024年 / 30卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
O126/2126
引用
收藏
页码：120 / 121
页数：2
相关论文
共 50 条
  • [31] Efficacy and safety of fampridine for walking disability in multiple sclerosis
    Arpin, Eva Costa
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2020, 10 (05) : 277 - 287
  • [32] Omalizumab in chronic inducible urticaria: A real-life study of efficacy, safety, predictors of treatment outcome and time to response
    Yu, Miao
    Terhorst-Molawi, Dorothea
    Altrichter, Sabine
    Hawro, Tomasz
    Chen, Yu-Di
    Liu, Bo
    Song, Xiao-ting
    Zhao, Zuo-tao
    Maurer, Marcus
    CLINICAL AND EXPERIMENTAL ALLERGY, 2021, 51 (05): : 730 - 734
  • [33] A real-life study of alemtuzumab in persons with multiple sclerosis: Kuwait's experience
    Alroughani, Raed
    AlMojel, Malak
    Al-Hashel, Jasem
    Ahmed, Samar Farouk
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 74
  • [34] Risk of secondary progression in patients with highly active multiple sclerosis treated with natalizumab: a real-life study
    Scherer, Louisa
    Soudant, Marc
    Pittion-Vouyovitch, Sophie
    Debouverie, Marc
    Guillemin, Francis
    Epstein, Jonathan
    Mathey, Guillaume
    JOURNAL OF NEUROLOGY, 2024, 271 (05) : 2216 - 2224
  • [35] multicenter prospective observational study on real-life experience with alemtuzumab in naive patients with aggressive multiple sclerosis
    Di Cristinzi, Maria
    Brambilla, Laura
    Rinaldi, Francesca
    Annovazzi, Pietro
    Zanetta, Chiara
    Frau, Jessica
    Lus, Giacomo
    Malucchi, Simona
    Puorro, Giorgia
    Bianco, Assunta
    Marfia, Girolama Alessandra
    Cavalla, Paola
    Cerqua, Raffaella
    Gallo, Antonio
    Lapucci, Caterina
    Filippi, Massimo
    Moiola, Lucia
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 620 - 621
  • [36] Italian multicenter observational study on real-life experience with alemtuzumab in naive patients with aggressive multiple sclerosis
    Moiola, Lucia
    Zanetta, Chiara
    Di Cristinzi, Maria
    Nozzolillo, Agostino
    Rinaldi, Francesca
    Brambilla, Laura
    Annovazzi, Pietro
    Lus, Giacomo
    Puorro, Giorgia
    Frau, Jessica
    Malucchi, Simona
    Bianco, Assunta
    Lapucci, Caterina
    Marfia, Girolama
    Gallo, Antonio
    Cerqua, Raffaella
    Cavalla, Paola
    Filippi, Massimo
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
  • [37] Risk of secondary progression in patients with highly active multiple sclerosis treated with natalizumab: a real-life study
    Louisa Scherer
    Marc Soudant
    Sophie Pittion-Vouyovitch
    Marc Debouverie
    Francis Guillemin
    Jonathan Epstein
    Guillaume Mathey
    Journal of Neurology, 2024, 271 : 2216 - 2224
  • [38] REAL-LIFE STUDY OF EFFICACY AND RESPONSE TO FIRST LINE TREATMENT IN PATIENTS WITH MULTIPLE MYELOMA CANDIDATES FOR TRANSPLANTATION. EXPERIENCE OF A CENTER
    Suarez Cabrera, A.
    Luzardo Henriquez, H.
    Gonzalvez, J.
    Perez, L.
    Guerra, L.
    Perera, M.
    Torres, M.
    Gomez Casares, M. T.
    Lemes, A.
    Gonzalez Perez, E.
    Saez Perdomo, M. N.
    Molero Labarta, T.
    Bravo de Laguna, Jimenez S.
    HAEMATOLOGICA, 2019, 104 : 20 - 20
  • [39] The impact of fampridine treatment on fatigue, quality of life and mood in patients with multiple sclerosis
    Barros, A.
    Sequeira, J.
    Vaz, S.
    Morgado, J.
    Bras, P.
    Melancia, D.
    Fernandes, A.
    Sousa, A.
    Dias, S.
    Capela, C.
    Pedrosa, R.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 688 - 688
  • [40] AUTHOR RESPONSE: MONITORING LONG-TERM EFFICACY OF FAMPRIDINE IN GAIT-IMPAIRED PATIENTS WITH MULTIPLE SCLEROSIS
    Filli, Linard
    Zoerner, Bjoern
    Killeen, Tim
    Linnebank, Michael
    NEUROLOGY, 2017, 89 (11) : 1200 - 1200
12345